The development of technetium-99m-labelled interleukin-2: A new radiopharmaceutical for the In vivo detection of mononuclear cell infiltrates in immune-mediated diseases

This publication has 14 references indexed in Scilit:

• A simple method for the evaluation of receptor binding capacity of modified cytokines
  Journal of Immunological Methods, 1993
• The IL-2 Receptor Complex: Its Structure, Function, and Target Genes
  Annual Review of Immunology, 1993
• A radiopharmaceutical for imaging areas of lymphocytic infiltration: 123I-interleukin-2. Labelling procedure and animal studies
  Nuclear Medicine Communications, 1992
• Specialization, Tolerance, Memory, Competition, Latency, and Strife among T Cells
  Annual Review of Immunology, 1992
• Radiolabeling of monoclonal antibodies and fragments with technetium and rhenium
  Bioconjugate Chemistry, 1992
• Interleukin-2 self-association
  Biochemical and Biophysical Research Communications, 1988
• DETECTION OF ACTIVATED LYMPHOCYTES IN ENDOCRINE PANCREAS OF BB/W RATS BY INJECTION OF 123I-INTERLEUKIN-2: AN EARLY SIGN OF TYPE 1 DIABETES
  The Lancet, 1987
• Hematologic effects of immunotherapy with lymphokine-activated killer cells and recombinant interleukin-2 in cancer patients
  Blood, 1987
• Reversed-phase chromatography of interleukin-2 muteins
  Journal of Chromatography A, 1986
• Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen.
  The Journal of Experimental Medicine, 1984